Soligenix Stock Investor Sentiment

SNGX Stock  USD 2.31  0.02  0.86%   
Slightly above 55% of Soligenix's investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Soligenix suggests that some traders are interested. Soligenix's investing sentiment can be driven by a variety of factors including economic data, Soligenix's earnings reports, geopolitical events, and overall market trends.
  

Soligenix Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Soligenix can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over two weeks ago at finance.yahoo.com         
Soligenix to Present at Upcoming Investor Conferences
Yahoo News
over two weeks ago at benzinga.com         
Soligenix Targets Psoriasis With New Therapy
benzinga news
over two weeks ago at finance.yahoo.com         
SNGX Additional Positive Outcomes in Investigator-Initiated Study of HyBryte in CTCL
Yahoo News
over two weeks ago at benzinga.com         
EXCLUSIVE Soligenixs Cancer Candidate Shows Encouraging Action With Extended Treatment At One Year
benzinga news
over two weeks ago at finance.yahoo.com         
EXCLUSIVE Soligenixs Cancer Candidate Shows Encouraging Action With Extended Treatment At One Year
Yahoo News
over two weeks ago at finance.yahoo.com         
HyBryte Expanded Treatment Continues to Demonstrate Positive Outcomes in Early-Stage Cutaneous T-Cel...
Yahoo News
over two weeks ago at thelincolnianonline.com         
Soligenix, Inc. Short Interest Down 67.1 percent in December
news
over two weeks ago at www.macroaxis.com         
Acquisition by Straube Richard of 12000 shares of Soligenix at 3.31 subject to Rule 16b-3
Macroaxis News
over three weeks ago at www.macroaxis.com         
Discretionary transaction by Pearson Mark E. of 932000 shares of Soligenix at 2.25 subject to Rule 1...
Macroaxis News
over a month ago at kalkinemedia.com         
Cutaneous T-Cell Lymphoma Market to Evolve Rapidly from 2024 to 2034 DelveInsight Angimmun, Philogen...
news
over a month ago at finance.yahoo.com         
SNGX Phase 3 FLASH2 Trial of HyBryte in CTCL Underway
Yahoo News
over a month ago at benzinga.com         
Soligenix Reports It Is On Cusp Of Treating Rare Cancer CTCL
benzinga news
over a month ago at benzinga.com         
EXCLUSIVE Soligenix Starts Confirmatory Late-Stage Trial For HyBryte For Type Of Blood Cancer
benzinga news
over a month ago at finance.yahoo.com         
Soligenix Initiates Confirmatory Phase 3 Clinical Trial of HyBryte for the Treatment of Cutaneous T-...
Yahoo News
over a month ago at finance.yahoo.com         
EXCLUSIVE Soligenix Starts Confirmatory Late-Stage Trial For HyBryte For Type Of Blood Cancer
Yahoo News
Far too much social signal, news, headlines, and media speculation about Soligenix that are available to investors today. That information is available publicly through Soligenix media outlets and privately through word of mouth or via Soligenix internal channels. However, regardless of the origin, that massive amount of Soligenix data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Soligenix news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Soligenix relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Soligenix's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Soligenix alpha.

Soligenix Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Soligenix Initiates a Phase 2 Clinical Trial of SGX945 for the treatment of Behets Disease
11/14/2024
2
Soligenix, A Pharmaceutical Firm Tackling Potentially Lucrative Unmet Medical Needs
11/26/2024
3
Acquisition by Lapointe Anthony Gregg of 29126 shares of Soligenix at 1.03 subject to Rule 16b-3
11/27/2024
4
Acquisition by Rubin Robert J. of 8646 shares of Soligenix at 3.47 subject to Rule 16b-3
12/12/2024
5
Soligenix Initiates Confirmatory Phase 3 Clinical Trial of HyBryte for the Treatment of Cutaneous T-Cell Lymphoma
12/16/2024
6
Cutaneous T-Cell Lymphoma Market to Evolve Rapidly from 2024 to 2034 DelveInsight Angimmun, Philogen, Soligenix
12/17/2024
7
Discretionary transaction by Pearson Mark E. of 932000 shares of Soligenix at 2.25 subject to Rule 16b-3
01/03/2025
8
Acquisition by Straube Richard of 12000 shares of Soligenix at 3.31 subject to Rule 16b-3
01/13/2025
9
EXCLUSIVE Soligenixs Cancer Candidate Shows Encouraging Action With Extended Treatment At One Year
01/14/2025
10
Soligenix to Present at Upcoming Investor Conferences
01/16/2025

Additional Tools for Soligenix Stock Analysis

When running Soligenix's price analysis, check to measure Soligenix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Soligenix is operating at the current time. Most of Soligenix's value examination focuses on studying past and present price action to predict the probability of Soligenix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Soligenix's price. Additionally, you may evaluate how the addition of Soligenix to your portfolios can decrease your overall portfolio volatility.